Who owns Oruka Therapeutics (ORKA)? Superinvestor holders

3 superinvestors of the 157 tracked here hold Oruka Therapeutics (ORKA) in their latest 13F filing, with $294.1M between them. Peter Kolchinsky gives it the most weight: 1.29% of the reported portfolio. In their latest reported quarter, Peter Kolchinsky and Polen Capital team opened a position; Andreas Halvorsen reduced.

Hold it now
3
of 157 tracked
Combined value
$294.1M
Bought / sold
2 / 1
last quarter

Key facts

Superinvestors holding it
3 of 157
Biggest holder
Peter Kolchinsky, $148M
Largest weight
Peter Kolchinsky, 1.29%of their portfolio
Combined value
$294.1M
Bought last quarter
2
Sold last quarter
1

From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.

Superinvestors holding ORKA, latest filings
#InvestorShare of their portfolioValueSharesLast quarterShares movedQuarter
1Peter KolchinskyRA Capital Management1.29%$148M1.55MNew+1.55MQ2 2026
2Andreas HalvorsenViking Global Investors0.41%$143.1M1.5M▼ Reduced 44%−1.16MQ2 2026
3Polen Capital teamPolen Capital Management0.03%$3M36.27KNew+36.27KQ3 2026

Quarter by quarter

Superinvestor ownership of ORKA by quarter
QuarterFilings inHoldersCombined sharesCombined valueBoughtSold
Q3 202692136.27K$3M10
Q2 202615723.06M$291M11
Q1 202615712.67M$130.8M00
Q4 202515712.67M$80.8M00
Q3 202515712.67M$51.3M10
Q2 20251570——00
Q1 20251560——00
Q4 20241560——00

A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.

Each holder's shares

Shares of ORKA held by each superinvestor, by quarter
InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Polen Capital team36.27K———————
Peter Kolchinsky·1.55M——————
Andreas Halvorsen·1.5M2.67M2.67M2.67M———

A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.

Questions and answers

Which superinvestors own ORKA?

In their latest 13F filings: Peter Kolchinsky (1.29% of the portfolio, $148M), Andreas Halvorsen (0.41% of the portfolio, $143.1M), Polen Capital team (0.03% of the portfolio, $3M).

Who bought ORKA last quarter?

Peter Kolchinsky (new position), Polen Capital team (new position). “Last quarter” is each investor's latest reported quarter.

Who sold ORKA last quarter?

Reduced: Andreas Halvorsen (44% fewer shares).

How current is this?

It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.

Learn

Cite this page

Funkfolio, “Who owns Oruka Therapeutics (ORKA)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/ORKA/superinvestors

Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.

Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to ORKA by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.